Effects of caffeine on heart rate and QT variability during sleep
Bonnet M, Tancer M, Uhde T, Yeragani VK
Depression and anxiety · 26 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2005-01-01 · Depress Anxiety · vol. 22 · número 3 · págs. 150–155
- Editorial
- Wiley
- Citado
- 46 citas · más que el 79% de estudios similares · 1.1× el promedio de su campo
- Referencias
- 49 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Heart Rate Variability and Autonomic Control · Coffee research and impacts · Sleep and related disorders
- Palabras clave
- caffeine, heart rate variability, QT interval variability, sleep, REM sleep, sleep stages, sympathetic nervous system, parasympathetic nervous system, LF/HF ratio, insomnia
- MeSH
- humans, long qt syndrome, caffeine, electrocardiography, wakefulness, sleep, sleep, rem, periodicity, heart rate, dose-response relationship, drug, algorithms
4 autores
- Michael H. Bonnet🇺🇸Wright State University; Dayton VA Medical Center
- Manuel E. Tancer🇺🇸Wayne State University
- Thomas W. Uhde🇺🇸Pennsylvania State University
- Vikram Kumar Yeragani🇨🇦🇺🇸 · autor de correspondenciaUniversity of Alberta; Wayne State University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Administration of caffeine in the evening produces poor sleep. Patients with insomnia have characteristic electrocardiogram (ECG) changes, including increased heart rate (HR), increased sympathetic activity, and decreased parasympathetic activity. Fifteen young adult normal subjects slept in the laboratory for several nights prior to randomization into a caffeine protocol where subjects received caffeine 400 mg 30 min prior to one night of sleep and placebo randomly prior to another night. ECG was sampled at a rate of 500 Hz and recorded onto a PC. Data samples of 256-s periods of the ECG trace were taken from wake (before sleep), stage II, and REM for placebo and caffeine conditions. A peak detection algorithm was used to identify the R-R intervals (in milliseconds) from the ECG. A common QT variability algorithm was used to find the QT interval for each beat using the time-stretch model. The powers for HR and QT series were integrated in the bands of LF (low frequency: 0.04-0.15 Hz) and HF (high frequency: 0.15-0.5 Hz) bands. There was a significant caffeine by sleep stage interaction for LF/HF ratios (F = 4.0; df = 2, 18; P = .04). LF/HF ratios were significantly higher during REM following caffeine administration. There was also a significant caffeine by sleep stage interaction for QTvi (QT variability normalized for mean QT interval divided by HR variability normalized for mean HR; F = 5.6; df = 2, 12; P = .02). QTvi was also significantly higher during REM following caffeine administration. The higher LF/HF ratios and QTvi during REM are most likely due to the sympathetic effects of caffeine. These findings suggest that excessive caffeine intake may result in adverse cardiovascular events in vulnerable subjects.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.